Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 10-19

  Sidhom, Mark A ^a   Kneebone, Andrew B ^a   Lehman, Margot ^b   Wiltshire, Kirsty L ^c   Millar, Jeremy L ^d   Mukherjee, Rahul K ^e   Shakespeare, Thomas P ^f   Tai, Keen Hun ^g  

^a LIVERPOOL HOSPITAL   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f North Coast Cancer Institute   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adjuvant; Clinical target volume; Consensus guidelines; Contouring guidelines; Prostate cancer; Prostatectomy; Radiation therapy; Salvage

Indexed keywords

ARTICLE; AUSTRALIA; CANCER RADIOTHERAPY; HIGH RISK PATIENT; HORMONAL THERAPY; MEDICAL EXPERT; MEDICAL PROFESSION; MEDICAL SOCIETY; NEW ZEALAND; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE;

AUSTRALIA; HUMANS; MALE; NEW ZEALAND; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY;

EID: 45849138565     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.006     Document Type: Article

References (56)

1. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
2. Thompson Jr. I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329-2335
3. Wiegel T., Bottke D., Willich N., et al. Phase III results of adjuvant radiotherapy (RT) versus "wait and see" in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96-02/AUO AP 09/95). J Clin Oncol 23 (2005) 4513
4. Do L.V., Do T.M., Smith R., and Parker R.G. Postoperative radiotherapy for carcinoma of the prostate: impact on both local control and distant disease-free survival. Am J Clin Oncol 25 (2002) 1-8
5. Choo R., Hruby G., Hong J., et al. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?. Int J Radiat Oncol Biol Phys 52 (2002) 674-680
6. Leibovich B.C., Engen D.E., Patterson D.E., et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 163 (2000) 1178-1182
7. Vicini F.A., Ziaja E.L., Kestin L.L., et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology 54 (1999) 111-117
8. National Health and Medical Research Council (NHMRC) publication: Guidelines for the development and implementation of clinical practice guidelines. Canberra: NHMRC; 1995.
9. Han M., Partin A.W., Pound C.R., Epstein J.I., and Walsh P.C. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
10. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., and Scardino P.T. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528-534
11. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
12. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
13. Catalona W.J., and Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152 (1994) 1837-1842
14. Kupelian P.A., Katcher J., Levin H.S., and Klein E.A. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys 37 (1997) 1043-1052
15. Pound C.R., Partin A.W., Epstein J.I., and Walsh P.C. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24 (1997) 395-406
16. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174 (2005) 903-907
17. Epstein J.I., Partin A.W., Sauvageot J., and Walsh P.C. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20 (1996) 286-292
18. Palapattu G.S., Allaf M.E., Trock B.J., Epstein J.I., and Walsh P.C. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 172 (2004) 1860-1864
19. Collette L., van Poppel H., Bolla M., et al. Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 41 (2005) 2662-2672
20. Tombal B, Debie B, Scaillet P, Van Cangh P. Immediate external beam radiation therapy (EBRT) after radical prostatectomy (PCa): long-term influence on QOL, urinary, and rectal symptoms. In: ASCO Prostate Cancer Symposium; 2006 [Abs. No. 123].
21. Cadeddu J.A., Partin A.W., DeWeese T.L., and Walsh P.C. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 159 (1998) 173-177
22. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 163 (2000) 845-850
23. Anscher M.S., Clough R., and Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 48 (2000) 369-375
24. Katz M.S., Zelefsky M.J., Venkatraman E.S., Fuks Z., Hummer A., and Leibel S.A. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 21 (2003) 483-489
25. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325-1332
26. Pazona J.F., Han M., Hawkins S.A., Roehl K.A., and Catalona W.J. Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates. J Urol 174 (2005) 1282-1286
27. Stephenson A.J., and Slawin K.M. The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy. Nat Clin Pract Urol 1 (2004) 90-96
28. Stephenson A.J., Kattan M.W., Eastham J.A., et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24 (2006) 3973-3978
29. MacDonald O.K., Schild S.E., Vora S., et al. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?. Urology 64 (2004) 760-764
30. Nudell D.M., Grossfeld G.D., Weinberg V.K., Roach III M., and Carroll P.R. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology 54 (1999) 1049-1057
31. Duchesne G.M., Dowling C., Frydenberg M., et al. Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: an Australian multicenter study. Urology 61 (2003) 179-183
32. Maier J., Forman J., Tekyi-Mensah S., Bolton S., Patel R., and Pontes J.E. Salvage radiation for a rising PSA following radical prostatectomy. Urol Oncol 22 (2004) 50-56
33. Cookson M.S., Aus G., Burnett A.L., et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177 (2007) 540-545
34. Zelefsky M.J., Aschkenasy E., Kelsen S., and Leibel S.A. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 39 (1997) 327-333
35. Van Cangh P.J., Richard F., Lorge F., et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 159 (1998) 164-166
36. Syndikus I., Pickles T., Kostashuk E., and Sullivan L.D. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. J Urol 155 (1996) 1983-1986
37. Formenti S.C., Lieskovsky G., Skinner D., Tsao-Wei D.D., Groshen S., and Petrovich Z. Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy. Urology 56 (2000) 453-458
38. Stephenson A.J., Pollack A., Kattan M.W., and Scardino P.T. Post-Prostatectomy Radiotherapy Consortium. Predicting the outcome of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 24 (2006) 4514 [Meeting abstracts]
39. Elias S., Parker R.G., Gallardo D., and Law J. Adjuvant radiation therapy after radical prostatectomy for carcinoma of the prostate. Am J Clin Oncol 20 (1997) 120-124
40. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360 (2002) 103-106
41. Pilepich M.V., Winter K., Lawton C.A., et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61 (2005) 1285-1290
42. Messing E.M., Manola J., Sarosdy M., Wilding G., Crawford E.D., and Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
43. Corn B.W., Winter K., and Pilepich M.V. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. Urology 54 (1999) 495-502
44. King C.R., Presti Jr. J.C., Gill H., Brooks J., and Hancock S.L. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?. Int J Radiat Oncol Biol Phys 59 (2004) 341-347
45. Eulau S.M., Tate D.J., Stamey T.A., Bagshaw M.A., and Hancock S.L. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys. 41 (1998) 735-740
46. Cheung R., Kamat A.M., de Crevoisier R., et al. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys 63 (2005) 134-140
47. Hayes S.B., and Pollack A. Parameters for treatment decisions for salvage radiation therapy. J Clin Oncol 23 (2005) 8204-8211
48. Valicenti R.K., Gomella L.G., Ismail M., et al. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology 52 (1998) 1034-1040
49. Wong G.W., Palazzi-Churas K.L., Jarrard D.F., et al. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys 70 (2008) 449-455
50. Wiltshire K., Brock K., Haider M., et al. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys 69 (2007) 1090-1099
51. Connolly J.A., Shinohara K., Presti Jr. J.C., and Carroll P.R. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 47 (1996) 225-231
52. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
53. Cozzarini C., Bolognesi A., Ceresoli G.L., et al. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 59 (2004) 674-683
54. Catalona W.J., and Smith D.S. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 160 (1998) 2428-2434
55. Parker C., Clarke N., Logue J., et al. RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol) 19 (2007) 167-171
56. Trans-Tasman Radiation Oncology Group 'RAVES' trial (Radiotherapy - Adjuvant Versus Early Salvage), personal correspondence with Dr. Maria Pearce, New Zealand: Auckland Hospital.